Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy
2014 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke
2015
Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study
2012 Standout
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples
2010
Ferroptosis: molecular mechanisms and health implications
2020 Standout
Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase
2012
Mechanisms, regulation and functions of the unfolded protein response
2020 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Pericytes are required for blood–brain barrier integrity during embryogenesis
2010 StandoutNature
Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners
2021
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
2016 Standout
Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. series
2016
The Blood–Brain Barrier
2015 Standout
Thrombo-inflammation in acute ischaemic stroke — implications for treatment
2019
Advances in metal-induced oxidative stress and human disease
2011 Standout
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Therapies for Hemorrhagic Transformation in Acute Ischemic Stroke
2017
Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis
2021
Obstructive Sleep Apnea Is Frequent in Patients with Hypertensive Intracerebral Hemorrhage and Is Related to Perihematoma Edema
2009
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
2021
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
2017
Toward online reconstruction of quantitative susceptibility maps: Superfast dipole inversion
2012
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
2007 Standout
Heritable and non-heritable uncommon causes of stroke
2020
The molecular machinery of regulated cell death
2019 Standout
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration
2017
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
2016 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
2016 Standout
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
2013
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives
2018
Mechanisms of hyperbaric oxygen and neuroprotection in stroke
2005
Subcutaneous and visceral adipose tissue: structural and functional differences
2009 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Predicting a post-thrombolysis intracerebral hemorrhage: a systematic review
2013
Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain
2012
Toll‐like receptor 4 contributes to poor outcome after intracerebral hemorrhage
2011 StandoutNobel
Angiotensin II Controls Occludin Function and Is Required for Blood–Brain Barrier Maintenance: Relevance to Multiple Sclerosis
2007
Inhibition of neuronal ferroptosis protects hemorrhagic brain
2017
PTEN Loss Increases PD-L1 Protein Expression and Affects the Correlation between PD-L1 Expression and Clinical Parameters in Colorectal Cancer
2013
Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions
2014
Hyperbaric Oxygen Therapy of Cerebral Ischemia
2005
Hepatocellular carcinoma
2022 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Risk of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke and High Cerebral Microbleed Burden
2016
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Hepatocellular Carcinoma
2019 Standout
Molecular Pathways: Next-Generation Immunotherapy—Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
2012
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10‐year intention‐to‐treat analysis
2017
A Pilot Study of Normobaric Oxygen Therapy in Acute Ischemic Stroke
2005
Treatment and Outcome of Thrombolysis-Related Hemorrhage
2015
IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs
2018
Role of Brain Iron Accumulation in Cognitive Dysfunction: Evidence from Animal Models and Human Studies
2013
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery
2018
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
2014 StandoutNobel
[Metabolic difference between visceral fat and subcutaneous abdominal fat].
2000
Activation of cerebral peroxisome proliferator‐activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase‐2 overexpression after focal cerebral ischemia in rats
2006
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
2015 Standout
A Double-Difference Earthquake Location Algorithm: Method and Application to the Northern Hayward Fault, California
2000 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Post‐thrombolytic blood pressure and symptomatic intracerebral hemorrhage
2016
PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
2013
Multiplet analysis at Coso geothermal
1998
Radiofrequency Ablation vs. Cryoablation for Localized Hepatocellular Carcinoma: A Propensity-matched Population Study
2018
Thrombolysis for acute ischaemic stroke
2014
Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
2016
2013
Clinical relevance of microbleeds in acute stroke thrombolysis
2016
Works of Min Lou being referenced
[Safety of intravenous thrombolysis in cerebral microbleeds patients with prior antiplatelet therapy].
2015
Characterization of geothermal reservoir crack patterns using shear-wave splitting
1997
Evaluation of Brain Iron Content Based on Magnetic Resonance Imaging (MRI): Comparison among Phase Value, R2* and Magnitude Signal Intensity
2012
Intravenous thrombolysis in Sneddon’s syndrome
2011
New Microbleeds After Thrombolysis
2014
Long-Term Outcomes of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma within Milan Criteria
2015
Cerebral Microbleeds: Burden Assessment by Using Quantitative Susceptibility Mapping
2011
Docosahexaenoic acid attenuates hyperglycemia-enhanced hemorrhagic transformation after transient focal cerebral ischemia in rats
2015
MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation
2016
Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping
2012
Extensive cerebral microbleeds predict parenchymal haemorrhage and poor outcome after intravenous thrombolysis
2015
Does Body Weight Influence the Response to Intravenous Tissue Plasminogen Activator in Stroke Patients?
2008
The Relationship between Hematoma Iron Content and Perihematoma Edema: An MRI Study
2009
Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma
2011
Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow
2018
The HAT Score
2008
Sustained Blockade of Brain AT1 Receptors before and after Focal Cerebral Ischemia Alleviates Neurologic Deficits and Reduces Neuronal Injury, Apoptosis, and Inflammatory Responses in the Rat
2004
Systolic Blood Pressure Variability is Associated with Severe Hemorrhagic Transformation in the Early Stage After Thrombolysis
2016
Therapeutic Window for Use of Hyperbaric Oxygenation in Focal Transient Ischemia in Rats
2004
Rationale and design of combination of an immune modulator Fingolimod with Alteplase bridging with Mechanical Thrombectomy in Acute Ischemic Stroke (FAMTAIS) trial
2017
[Impact of cerebral microbleeds on outcomes of acute ischemic stroke treated with intravenous thrombolysis].
2014
Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma
2014